N OH O COOH NH OH MW: 382.4 g/mol COMPOUND REF: HUB-GLK1-037 CAS: 910463-68-2

Solutions for Pharmaceutical & Biotech Brand Protection Teams

Counterfeit Medicines Don't Just
Harm Brands. They
Harm Patients.

Human Expertise. Amplified.

The fastest-growing counterfeit medicine threat in 2026 isn't in developing markets — it's on social media, in online pharmacies, and in the supply chains serving GLP-1 drugs like semaglutide. The explosion of demand for weight-loss medications has created a counterfeit ecosystem that moves faster than traditional enforcement. Hubstream connects your seizure data, marketplace intelligence, online pharmacy monitoring, and enforcement actions into one network view — so your team can protect patients, not just brand revenue.

Used by teams across
GLP-1 & Weight Loss Oncology Branded Generics Vaccines Medical Devices

Patterns · 01–08

Sound Familiar?

Every brand protection team has had these conversations

"We're seeing Ozempic fakes on Instagram, Telegram, and TikTok. The velocity is unlike anything before."
"A patient reported a suspected fake through our adverse event line. We couldn't tell the batch origin."
"We have seizure data from customs and reports from social media monitoring. They've never been connected."
"Online pharmacies are advertising our drug without authorization. We don't know if they're connected."
"Legal needs a brief on the counterfeit network. It would take weeks to compile from what we have."
"We know the distribution network spans three countries. We can't prove it because the data is siloed."
"Our enforcement team took down a fake product listing. The same seller had 40 more we missed."
"We flagged this online pharmacy to our team in EMEA. They'd already been tracking the same group."
"We're seeing Ozempic fakes on Instagram, Telegram, and TikTok. The velocity is unlike anything before."
"A patient reported a suspected fake through our adverse event line. We couldn't tell the batch origin."
"We have seizure data from customs and reports from social media monitoring. They've never been connected."
"Online pharmacies are advertising our drug without authorization. We don't know if they're connected."
"Legal needs a brief on the counterfeit network. It would take weeks to compile from what we have."
"We know the distribution network spans three countries. We can't prove it because the data is siloed."
"Our enforcement team took down a fake product listing. The same seller had 40 more we missed."
"We flagged this online pharmacy to our team in EMEA. They'd already been tracking the same group."
Connection · Before · After

Why Siloed Data
Puts Patients at Risk

Every disconnected data source is a gap that counterfeit networks exploit. Hubstream closes the gaps.

Before Hubstream

Multiple
Disconnected Dots

Customs Seizures Adverse Event Reports Social Media Flags Pharmacy Intelligence Legal Actions Test Buy Results

Each data point isolated — the network supplying patients with fakes stays invisible

After Hubstream

A Connected
Counterfeit Network

Instagram Telegram Ch. Online Pharm. Customs Seizure Adverse Events SUPPLIER — IDENTIFIED
Outcomes · 01–04

What You Get

Four things pharmaceutical and biotech brand protection teams get from Hubstream — that no single monitoring tool can deliver alone.

01 / Patient Safety · Proactive Intelligence

Identify Counterfeit Networks
Before Patients Are Harmed.

The fastest way to protect patients is to dismantle the network supplying them.

Counterfeit medicine networks don't wait for your team to catch up. Hubstream connects your seizure data, marketplace intelligence, and adverse event reports so your team can identify the distribution network before it reaches more patients.

  • Seizure + adverse event + marketplace — connected
  • Network identification before harm scales
  • Proactive enforcement targeting
02 / Intelligence Unification · Cross-Data Analysis

Connect Seizure, Adverse Event,
and Marketplace Data.

Siloed data is a gap that counterfeit networks exploit.

Your seizure team, your pharmacovigilance team, and your marketplace monitoring team all have pieces of the same picture. Hubstream connects them — so instead of three separate investigations, you have one unified view of the threat.

  • Cross-department data integration
  • Unified counterfeit network view
  • Elimination of intelligence silos
03 / Regulatory Intelligence · Authority Coordination

Brief Regulators and Law Enforcement
with Packaged Intelligence.

Actionable intelligence your enforcement partners can actually use.

Regulatory and law enforcement agencies want to act — they need packaged, actionable intelligence to do so. Hubstream structures your enforcement data into briefings that health authorities, customs, and law enforcement can act on immediately.

  • Regulator-ready intelligence briefings
  • Law enforcement coordination support
  • Patient safety alert preparation
04 / Outcome Reporting · Executive Briefings

Report on Patient Safety Outcomes,
Not Just Takedown Counts.

Your leadership needs to know what your program is protecting, not just what it's removing.

Takedown volume is a metric. Patient safety is an outcome. Hubstream gives your team the data to demonstrate the real impact of your brand protection program — in terms your board, regulatory affairs, and legal teams all understand.

  • Patient safety impact reporting
  • Network disruption metrics
  • Board-ready outcome summaries
Prevention · Featured Industry
Case Study

Global Pharmaceutical Company

Identifying a counterfeit GLP-1 distribution network operating across social media and online pharmacies.

1 Network Dismantled — spanning social media, unlicensed online pharmacies, and 3-country supply chain, identified within weeks
"The counterfeits were reaching patients through social media channels that were harder to monitor than traditional market channels. Connecting our seizure data, online pharmacy intelligence, and adverse event reports gave us the picture we needed to act."
Outcomes
  • 01 / Connected social media distribution channels, unlicensed online pharmacy activity, and customs seizure records to identify a coordinated counterfeit GLP-1 distribution network operating across five countries.
  • 02 / Identified the primary supplier and fulfilment operations, enabling coordinated enforcement action with customs and health regulatory authorities in three jurisdictions.
  • 03 / Provided packaged intelligence briefings to health authorities and law enforcement agencies in support of patient safety alerts and coordinated market withdrawals.
  • 04 / Dismantled the primary distribution network, significantly reducing the availability of counterfeit product in identified channels within 90 days of network identification.
Playbooks

Proven Pharma Brand Protection
Workflow Templates

Operational frameworks built for pharmaceutical and biotech brand protection teams. Download free — no demo required.

  • 01 / Online Anti-Counterfeit (Pharma)
  • 02 / Customs Seizure Management
  • 03 / Adverse Event & Fake Product Reporting
  • 04 / Online Pharmacy Monitoring
  • 05 / Regulatory Intelligence Briefings
  • 06 / Executive Reporting
Free Download

Get the Template Library

6 operational playbooks for brand protection teams. Delivered instantly to your inbox.

No spam. Unsubscribe any time.

Ready to see the network?

See Hubstream
In Action

We'll walk you through how Hubstream connects your enforcement data, seizure records, and third-party intelligence — and show you exactly what your threat network looks like when it's all in one place.